Chronic kidney disease (CKD) is a non-communicable disease, and a major public health problem ranked as the 12^th cause of death worldwide in 2017 [1]. Its final common pathway, End Stage Kidney Failure (ESKF), is associated with considerable morbidity and mortality [2] [3]. It is estimated that by 2030, 70% of patients with ESKF will originate from low- and middle income countries (LMICs), such as those in sub-Saharan Africa [4] [5]. This is driven by population aging, the double burden of infectious diseases and the growing problems of other non- communicable diseases such as obesity, diabetes mellitus and hypertension [6] [7] [8]. Once the kidneys fail, renal replacement therapy (RRT) is the only means of survival [9] [10]. Where available, haemodialysis predominates because of frequent unavailability and higher costs of peritoneal dialysis or transplantation [11] [12]. However, dialysis patient mortality is unacceptably high, currently approximately 20% per year in the United States [13]. The mortality rate within 90 days of commencing RRT in SSA countries is as high as 90%, compared with European countries where it is about 3% [4] [14]. Despite the technical advances in haemodialysis [13] [15], the mortality of patients with ESKF is 10 to 30 times higher than that of the general population [4]. In developing countries, the mortality is even higher due to the lack of human, financial and material resources [16]. The mortality among incident haemodialysis patients in Cameroon was reported to be 39% [8], with the most common causes of death being cardiovascular, infectious disease, uremic complications and anaemia [17] [18] [19]. Cardiovascular diseases are the leading [20] cause of death in ESKF patients; cardiac arrest accounts for 47.1% of total deaths [21] [22]. Knowing whether risk factors for mortality differ in dialysis patients who survive longer and the strengths of these risk factors for mortality change over time would assist physicians in making better prognostic judgments [23]. Few studies have performed a comprehensive analysis of the prognostic importance [2] of comorbidities, age, sex, nutritional status in incident dialysis patients’ survival [24] [25] [26]. Cardiovascular disease and the timing of dialysis initiation have equally served as important prognostic markers of survival, independent of other factors [25] [27]. In our setting, data on the early mortality, the causes of death and its predictors is scarce, hence the interest of this work.

The aim of this study was to determine the 120 day mortality rate, identify the causes of death and discuss its predictors among incident haemodialysis patients with ESKF at Douala General Hospital and Buea Regional Hospital from January 2016 to December 2020. At the end of the study; 1012 patients registered in these centres over the study period, 258 deaths were recorded within 120 days thus a rate of 25.5% (23, 1% at DGH and 28, 6% at BRH). The main causes of death were sepsis (47.5%), cardiovascular diseases (13.4%), and anaemia (10.3%). Sepsis among these patients originated principally from catheters (77.9%), and the lungs (9.0%). Cardiovascular deaths were mostly sudden deaths (76.2%), myocardial infarction (9.5%) and heart failure (9.5%). Older age, cardiovascular disease, having a catheter as first vascular access, Albumin ≤ 3.5 g/l, CRP > 12 mg/l,

CRP, C-reactive protein. ** means significant value.

AOR, Adjusted Odds Ratio, CVD, Cardiovascular disease, CRP, C-reactive protein. ** means significant value.

Creatinine > 20 mg/dl, and Urea > 300 mg/dl were associated with mortality. After multivariate analysis, cardiovascular disease, Albumin ≤ 3.5 g/l, and Creatinine > 20 mg/dl were independent predictors of mortality.

Early mortality among incident haemodialysis patients is still very high despite the technical and pharmacological advances in the field of medicine. We recorded a rate of 25.5%, which was similar to 27.5% reported by Ortiz et al. in the US in 2011 [20]. Halle et al. in 2013 recorded a higher mortality of 34%, Fouda et al. in 2005 had a 90 day mortality about twice that of our study [4] [16]. This drop in mortality could be explained by the fact that there has been an increase in the number of haemodialysis centres in the country passing from 3 to more than 8 centres. Our mortality rate was otherwise at least four times that recorded by Tsakiris et al., Ansell et al. and Mcquillan et al. which were respectively 3.9%, 5.8% and 6.3% [28] [29] [30]. This great disparity could be explained by the fact that RRT in our setting albeit available is limited, there is insufficient pre-dialytic care as well as the cost associated with the management of ESKD, its comorbidities and complications [31] [32]. Luyckx et al. in 2013 quoted that; many people whose kidneys fail can expect to live long, but only if they live in rich countries [33].

Mortality was higher at the BRH compared to the DGH. This could be explained by the fact that the DGH is an older centre, and also as a tertiary hospital has a better technical plateau in terms of staff and material. This will definitely imply a better management of these patients, their comorbid conditions and complications. Also, more patients at the DGH are insured and this goes a great deal with the cost of care. In addition to this, a good number of patients at the BRH come from rural areas and access is not the best. With the ongoing socio-political crisis, there are also shortcomings with transportation and accessibility.

The principal cause of death was sepsis (n = 78; 47.5%), with catheter as the principal origin of sepsis (77.9%, n = 60) throughout this period. This is similar to other studies in developing countries where sepsis was reported as the first cause of death, this was the case in Ethiopia were sepsis accounted for 34.1% of causes of death, in Saudi Arabia where it was 45% [9] [34]. In these, catheters were yet the most common origin of sepsis. This high level of death due to sepsis could still be explained by the excessive use of temporal catheters at initiation of dialysis which is a risk factor for developing infections. Cardiovascular diseases represented the second causes of death (12.82%), as was equally reported in the same studies above [9] [34]. Sudden death (76.2%), myocardial infarction (9.5%) and heart failure (9.5%) were the main cardiovascular causes of death in our study. Even though in literature cardiovascular diseases are the main causes of death, it takes the second position in low income countries probably because of the burden of infectious diseases in these countries, lack of pre dialysis follow up as seen with the use of temporal catheters for dialysis and the poor management of complications associated with ESKF. This is however different from the studies done in developed countries, where cardiovascular death is still the leading cause of death. This was the case in Canada (34.2%), South Korea (41.6%) [30] [35]. Among cardiovascular deaths, sudden death was the most frequent, a finding similarly reported in the above studies. This difference with high income countries could be explained by their population entering dialysis at an elderly age, above 65 years and presenting with numerous cardiovascular comorbidities, coupled with their quality of care [36]. Anaemia was the third cause of death, accounting for 9.94% and was more prevalent in females (p = 0.003). This could be explained by the cost of care with anaemia, notably: blood transfusions, the use of erythropoietin (EPO) and this poses a financial burden. Though we did not evaluate the impact of economic status due to the retrospective nature of our study, women are usually underprivileged and unemployment is more encountered amongst them. This was reported by Halle et al. in 2015 in one of these centres [37]. Uraemia accounted for 8.8% of deaths, which was less than that reported by Fouda et al. [16]. This could be explained by the fact that there were fewer haemodialysis centres during her study period and patient this could not accommodate the ESKF population in the country at the time.

We found that several factors were associated with mortality. These included; older age, having a catheter as first vascular access type, cardiovascular disease, Albumin ≤ 3.5 g/l, CRP > 12 mg/l, Creatinine > 20 mg/dl, and Urea > 300 mg/dl. After logistic regression, cardiovascular disease, Albumin ≤ 3.5 g/l, and Creatinine > 20 mg/dl were independent predictors of mortality. Cardiovascular disease has been reported as a predictor of mortality in a number of studies. This was reported by Bradbury et al. in 2007 in the Dialysis Outcomes and Practice Patterns Study and Mcquillan et al. in 2012 in Canada [13] [30]. In a study done by Tong et al. in 2015, CVD was associated with worse survival rates in dialysis patients [38], Foley et al. in 2012 reported CVD-related mortality in dialysis patients to be 10 to 20 times higher than in the general population [39]. Hypoalbuminemia (albumin ≤ 3.5 g/l) was associated with mortality. Inflammatory states, under nutrition amongst our population, could be responsible for this picture, as equally reported by Canaud et al. in 2013 [40]. It is very likely that much of the influence of nutritional biochemical parameters, particularly albumin, on the morbidity and mortality of dialysis is explained by the relationship between inflammation and this parameter [24] [41]. It has been reported that in the presence of chronic inflammation, malnourished patients have very low albumin levels, a sign of severity of malnutrition or a reflection of resistance to treatment [42]. Lukowsky et al. in 2012 showed that a higher creatinine at dialysis initiation was associated with mortality, similarly for higher urea levels [17]. The above association summarises the disconcerting high rate of late referral to nephrologists in our setting, with already worsened renal failure at HD initiation [37]. Similarly, an inverse relationship has been described between creatinine and mortality owing to sarcopenia/protein energy malnutrition [43] [44].

We acknowledge some limitations to this study. The retrospective nature of our study makes a lot of data missing. The mortality rate calculated above is probably just an underestimate as some patient deaths may not have been reported, and others lost to follow-up. The causes of death were based on clinical judgement and individual perception of the nephrologist or general practitioner during last admission or medical visit. Nonetheless, this was a multicentre study at different levels of care.

One in four patients on haemodialysis die early. Cardiovascular disease, hypo- albuminemia, and worsened renal failure were predictors of mortality. Majority of patients die from preventable causes, the main ones were sepsis from catheter, cardiovascular diseases, and severe anaemia.

The authors declare no conflicts of interest regarding the publication of this paper.

Teuwafeu, D.G., Fopa, D.F.M., Patrice, H.M., Gobina, R., Mahamat, M., Fouda, H. and Francois, K.F. (2022) Early Mortality (120 Days) amongst Incident Hemodialysis with End Stage Kidney Disease: A 5-Year Retrospective Study. Open Journal of Nephrology, 12, 332-346. https://doi.org/10.4236/ojneph.2022.123034

BRH: Buea Regional Hospital,

CKD: Chronic Kidney Disease,

CVD: Cardiovascular Disease,

DGH: Douala General Hospital,

ESKF: End Stage Kidney Failure,

HD: Haemodialysis,

HIV: Human Immunodeficiency Virus,

IHD: Incident Haemodialysis,

LMICs: Low and Middle Income Countries,

NCDs: Non-Communicable Diseases,

RRT: Renal Replacement Therapy,

SSA: Sub-Saharan Africa,

WHO: World Health Organisation.